Cortisol and ACTH Measurements at Extubation From Pituitary Surgery Predicts Hypothalamic-Pituitary-Adrenal Axis Function.
J Endocr Soc
; 7(4): bvad025, 2023 Feb 09.
Article
em En
| MEDLINE
| ID: mdl-36846212
ABSTRACT
Context Early prediction of hypothalamic-pituitary-adrenal (HPA) axis function following transsphenoidal surgery (TSS) can improve patient safety and reduce costs. Objective:
Systematic measurement of ACTH and cortisol at extubation following anesthesia to predict remission from Cushing's disease (CD) and HPA axis preservation following non-CD surgery.Design:
Retrospective analysis of clinical data between August 2015 and May 2022.Setting:
Referral center. Patients Consecutive patients (n = 129) undergoing TSS who had perioperative ACTH and cortisol measurements.Interventions:
ACTH and cortisol measurement at extubation. Further serial 6-hourly measurements in CD patients. Main outcomemeasures:
Prediction of future HPA axis status based on ACTH/cortisol at extubation.Results:
ACTH and cortisol increased sharply in all patients at extubation. CD patients (n = 101) had lower ACTH values than non-CD patients (110.1 vs 293.1â pg/mL; P < 0.01). In non-CD patients, lower plasma ACTH at extubation predicted the need for eventual corticosteroid replacement (105.8 vs 449.1â pg/mL, P < 0.01). In CD patients, the peak post-extubation cortisol at 6â hours was a robust predictor for nonremission (60.7 vs 219.2â µg/dL, P = 0.03). However, normalized early postoperative value (NEPV; the post-extubation values minus the peak preoperative CRH or desmopressin test values) of cortisol reliably distinguished nonremission earlier, at the time of extubation (-6.1 vs 5.9, P = 0.01), and later.Conclusions:
We found that at extubation following TSS, ACTH can predict the need for eventual steroid replacement in non-Cushing's patients. In patients with CD, we found a robust prediction of nonremission with NEPV cortisol at extubation and later.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
J Endocr Soc
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Estados Unidos